News

Incoco Capital Unveils New Skyscraper Development Plans

Incoco Capital Unveils New Skyscraper Development Plans

Exciting New Developments from Incoco Capital

Incoco Capital, in collaboration with Charney Companies and Tavros, proudly announces the groundbreaking of a stunning 55-story skyscraper located at Court Square. This project promises to redefine luxury living with exciting amenities and a prime location.

Key Highlights of the New Skyscraper

The upcoming condominium will encompass both 24-19 Jackson Avenue and 45-03 23rd Street, although a formal name for the building has yet to be established. Strategically positioned at the convergence of three major boroughs, it will offer unparalleled access to transportation, fitness centers, shopping, and exquisite design.

The Journey to Groundbreaking

For a considerable period, Charney and Tavros meticulously assembled properties for the design of this high-rise, a process that began in 2016. Their dedication culminated in the acquisition of seven adjoining townhouse properties, coupled with securing air rights from two additional locations. A pivotal moment occurred when Incoco Capital partnered and doubled the site size by purchasing extra land from a notable hotel chain, enabling a comprehensive design vision.

Vision and Leadership

Incoco Capital stands as a respected real estate investment management and development firm holding offices in New York City, New Jersey, and Korea. Fa Park, the Chairman and Founder, expresses confidence in the project's potential, stating, "We are exploring various investment opportunities, particularly in light of the job creation this skyscraper will facilitate."

Sam Charney, Principal of Charney Companies, remarked, "Creating condos in an energetic NYC neighborhood is thrilling. Our team's unwavering commitment and vision have been crucial in reaching this significant milestone. We have faced challenges, but with the support of our esteemed partners, we turn this vision into reality."

Architectural Design and Amenities

The architectural brilliance of this skyscraper is brought to life by FXCollaborative, promising a range of living spaces from studios to four-bedroom homes. Residents will enjoy an extensive amenity package, including a premier grocery store and a state-of-the-art fitness center, further enhancing the living experience.

Environmental and Economic Impact

Nicholas Silvers, Founding Partner of Tavros, shares his enthusiasm for the project, stating, "Commencing construction on this breathtaking site has been a long-awaited goal. The completed building will not only offer stunning views but also provide a well-designed living experience in an incredibly convenient location."

The location at Court Square serves as a transport hub, with access to various subway lines and bus routes, ensuring seamless connectivity to and from the city. Additionally, residents can enjoy diverse culinary options, cultural institutions, and vibrant parks nearby.

Looking Ahead

Occupancy for the skyscraper is projected to begin in the spring of 2028, marking a new chapter in luxury living in the heart of the city. As this ambitious project takes shape, it signifies a remarkable collaboration among industry leaders committed to shaping the future of real estate development.

About the Partners

About Incoco Capital, LLC:
Incoco Capital is a seasoned real estate investment management firm that has diversified into real estate development alongside its strong investment history. The firm focuses on projects within the metropolitan area, applying its expertise to yield significant returns.

About Charney Companies:
Founded in 2013, Charney Companies is dedicated to high-quality development and management, playing a vital role in the New York City Metro real estate market. Their commitment spans from construction to adaptive reuse projects, ensuring a robust presence in the industry.

About Tavros:
Tavros operates as a dedicated real estate investment management firm. It emphasizes the importance of its relationships with tenants and stakeholders, ensuring a quality living experience rooted in high standards.

Frequently Asked Questions

What is the location of the new skyscraper?

The skyscraper is situated at Court Square in Long Island City and will integrate multiple transportation options for easy access.

What amenities will the skyscraper offer?

Residents can expect a premier amenities package, including a best-in-class grocery store and a fitness center, among other luxurious features.

Who are the developers behind this project?

The project is a collaboration between Incoco Capital, Charney Companies, and Tavros, each contributing their expertise to bring this vision to life.

When is the expected occupancy?

Occupancy is projected to begin in the spring of 2028, allowing future residents to look forward to moving into their new homes.

What types of living spaces will be available?

The skyscraper will offer a range of living options, including studios, one-, two-, three-, and four-bedroom homes to cater to a variety of lifestyles.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 248

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 34

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 497

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 17

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 336

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 81

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 62

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 83

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 281

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 493

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

FPI Earnings Preview: Traders Eye EPS and Guidance Impact

Updated Category News Views 158

Farmland Partners (NYSE:FPI) is prepped to drop its quarterly earnings on February 18, 2026, and you better believe traders are already sweating over it. Analysts are throwing out estimates pegging the earnings per share (EPS) at $0.19—now, that's not exactly a home run but it's enough to keep eyes glued to the screens as we await the news. The buzz in the air is thick;...

Continue Reading
Reviva Pharmaceuticals Engages Investors at 2025 Summit

Updated Category News Views 312

Reviva Pharmaceuticals Attending the 2025 Investor Healthcare Summit Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is a leader in the biopharmaceutical industry, committed to developing cutting-edge therapies that cater to unmet medical needs. This January, Reviva will have an influential presence at the upcoming Lytham Partners 2025 Investor Healthcare Summit....

Continue Reading
Genpact's Q1 2025 Financial Highlights and Future Outlook

Updated Category News Views 886

Financial Performance Overview for Genpact Genpact Limited (NYSE: G) has reported outstanding net revenues of $1.215 billion for the first quarter of 2025, reflecting a robust growth rate of 7.4% year-over-year, or 8.3% when adjusted for constant currency fluctuations. This growth has been fueled by an impressive performance in its Data-Tech-AI segment, which generated...

Continue Reading
Multinational Investments: How to Reach More Countries

Updated Category Investing Views 706

Global expansion has become a strategic priority for companies seeking long-term growth. Markets mature, local competition intensifies, and consumer expectations evolve quickly. As a result, multinational investments are no longer reserved for massive corporations. Mid-sized and even smaller firms are exploring foreign markets to diversify revenue and increase resilience....

Continue Reading
Nobu Hospitality Unveils Luxury Residential Options in Kraków

Updated Category News Views 126

Nobu Hospitality Expands Its Luxury Footprint Nobu Hospitality is a name synonymous with luxury and refinement in the hospitality industry, expanding its prestigious brand into new territories. One of its latest ventures takes a significant leap into a magnificent city rich in history—Kraków. This development marks a notable milestone as it is Nobu's first residential...

Continue Reading